Surplus Solutions Expands Global Offerings with Refurbished

FierceBiotechCharles River debuts AI diagnostic tool to cut down pathology timelines

10x Genomics NewsThis $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116% - The Motley Fool

Endpoints NewsWhat I learned at a journalism fellowship about covering healthcare AI

BioPharma DiveArvinas, Pfizer find new partner for ‘Protac’ breast cancer drug

FierceBiotechAlphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model

Endpoints NewsFive burning Qs for Isomorphic Labs after $2.1B raise for AI biotech

Lonza NewsLonza Launches Xcite AAV Producer Cell Line Platform - Contract Pharma

Endpoints NewsPfizer and Arvinas give disappointing breast cancer drug to Rigel

FierceBiotechBoehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas asset

Endpoints NewsBayer to make 'careful but aggressive' return to pharma M&A, CEO says

Endpoints NewsAlkermes' narcolepsy Phase 3 success; Boehringer's antibody deal

FierceBiotechAstraZeneca’s $800M bet undermined by immunogenicity in phase 3